Iovance Biotherapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference
14 févr. 2018 08h00 HE
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating...